University of California San Francisco
Helen Diller Family Comprehensive Cancer Center
Johannes Kratz, MD

Johannes Kratz, MD

Assistant Professor in Residence, Cardiothoracic Surgery, UCSF

Cancer Center Program Memberships

Experimental Therapeutics

Research Summary

Johannes R. Kratz, M.D. is Director of Minimally Invasive and Robotic Thoracic Surgery and holds the Van Auken Endowed Chair in Thoracic Oncology. Kratz graduated magna cum laude from Harvard Medical School and holds a Masters in Philosophy from Stanford.

Kratz worked as research fellow in the Thoracic Oncology Lab from 2008-2011 where he played a pivotal role in the development of a prognostic assay for early-stage lung cancer patients. The novel assay was validated in an international clinical trial led by thoracic surgeons David M. Jablons, M.D. and Michael Mann, M.D. The assay better predicted risk of death in early-stage lung cancer patients versus conventional staging guidelines and later successfully identified Stage 1A lung cancer patients who had a very high likelihood of mortality after surgery. Kratz finished his clinical training as a clinical fellow in Thoracic Surgery at UCSF from 2014 - 2017.

Kratz has published numerous papers and has been the recipient of numerous awards and honors including the Partners Healthcare Resident/Fellow as Teacher Award, Willard M. Daggett Award, Edward Churchill Surgical Research Fellowship, Wyeth Scholarship of the American College of Surgeons, John E. Thayer Scholarship Award, Howard Hughes Medical Fellows Program Continued Support Award, Howard Hughes Medical Student Research Fellowship, and designation as a Soma Weiss Scholar.

Education

  • Stanford University, Palo Alto, CA, B.A. (with Distinction), 06/1999, Philosophy
  • Stanford University, Palo Alto, CA, B.S. (with Honors with Distinction), 06/1999, Biological Sciences
  • Stanford University, Palo Alto, CA, M.A., 06/2000, Philosophy
  • Harvard Medical School, Boston, MA, M.D. (Magna cum laude), 06/2006
  • Massachusetts General Hospital, Boston, MA, Residency, 06/2014, General Surgery
  • University of California, San Francisco, CA, Post-Doctoral Research Fellowship, 06/2011, Thoracic Oncology
  • University of California, San Francisco, CA, Fellowship, 06/2017, Cardiothoracic Surgery

Professional Experience

  1. 2017-present
    Assistant Professor in Residence, Cardiothoracic Surgery, University of California, San Francisco
  2. 2017-present
    Associate Program Director, Cardiothoracic Surgery, University of California, San Francisco
  3. 2017-present
    Director, Minimally Invasive and Robotic Thoracic Surgery, Cardiothoracic Surgery, University of California, San Francisco
  4. 2017-present
    Program Leader, Enhanced Recovery After Thoracic Surgery, Cardiothoracic Surgery, University of California, San Francisco

Honors & Awards

  • 2005
    Soma Weiss Scholar Award, Harvard Medical School
  • 2006
    John E. Thayer Scholarship Award, Harvard Medical School
  • 2010
    Willard M. Daggett Award, Massachusetts General Hospital
  • 2011
    President's Conference Selection, World Conference on Lung Cancer, International Association for the Study of Lung Cancer
  • 2012
    First Place, Oral Presentation, Harvard Medical School Surgery Research Conference, Harvard Medical School
  • 2012
    Partners HealthCare Resident/Fellow as Teacher Award (awarded to one resident among all specialties across all eleven Partners HealthCare hospitals), Partners HealthCare
  • 2017
    UCSF Health Exceptional Physician Award (awarded for Professionalism, Respect, Integrity, Diversity and Excellence), UCSF
  • 2018
    Van Auken Endowed Chair in Thoracic Oncology, University of California, San Francisco

Selected Publications

  1. Haro GJ, Sheu B, Marcus SG, Sarin A, Campbell L, Jablons DM, Kratz JR. Perioperative Lung Resection Outcomes After Implementation of a Multidisciplinary, Evidence-based Thoracic ERAS Program. Ann Surg. 2019 Dec 05.
    View on PubMed
  2. Haro GJ, Sheu B, Cook NR, Woodard GA, Mann MJ, Kratz JR. Comparison of Conventional TNM and Novel TNMB Staging Systems for Non-Small Cell Lung Cancer. JAMA Netw Open. 2019 12 02; 2(12):e1917062.
    View on PubMed
  3. Greg J. Haro, Fang Yu Sheu, Stanley J. Rogers, David M. Jablons, Johannes R. Kratz. Esophagectomy Outcomes after Implementation of an Enhanced Recovery after Surgery Program. Journal of the American College of Surgeons. 2019 Oct 1; 229(4):s277.
    View on PubMed
  4. G. Woodard, V. Ding, I. Kim, K. Jones, G. Chavez, G. Haro, J. Kratz, M. Mann, J. Rotow, C. Blakely, D. Jablons. MA06.09 Timing of Driver Mutation Development and the Genetic Evolution of Semi-Solid Lung Nodules into Early NSCLC. Journal of Thoracic Oncology. 2019 Oct 1; 14(10):s271-s272.
    View on PubMed
  5. J. Rotow, A. Urisman, C. Mccoach, T. Jahan, T. Bivona, K. Jones, A. Gupta, H. Do, J. Riess, D. Aisner, R. Doebele, D. Jablons, J. Kratz, C. Blakely. P1.14-58 A Phase II Study to Evaluate Neoadjuvant Osimertinib for Surgically Resectable, EGFR-Mutant Non-Small Cell Lung Cancer. Journal of Thoracic Oncology. 2019 Oct 1; 14(10):s578.
    View on PubMed
  6. Jiang L, Tolani B, Yeh CC, Fan Y, Reza JA, Horvai AE, Xia E, Kratz JR, Jablons DM, Mann MJ. Differential gene expression identifies KRT7 and MUC1 as potential metastasis-specific targets in sarcoma. Cancer Manag Res. 2019; 11:8209-8218.
    View on PubMed
  7. Kratz JR, Haro GJ, Cook NR, He J, Van Den Eeden SK, Woodard GA, Gubens MA, Jahan TM, Jones KD, Kim IJ, He B, Jablons DM, Mann MJ. Incorporation of a Molecular Prognostic Classifier Improves Conventional Non-Small Cell Lung Cancer Staging. J Thorac Oncol. 2019 07; 14(7):1223-1232.
    View on PubMed
  8. Lancaster EM, Jablons D, Kratz JR. Applications of Next-Generation Sequencing in Neoantigen Prediction and Cancer Vaccine Development. Genet Test Mol Biomarkers. 2020 Feb; 24(2):59-66.
    View on PubMed
  9. Haro GJ, Seeley EJ, Jablons DM, Kratz JR. Central Airway Obstruction Due to Tracheal Glomus Tumor. Thorac Cardiovasc Surg Rep. 2018 Jan; 7(1):e43-e45.
    View on PubMed
  10. Ramirez JL, Kratz JR, Wieselthaler GM. Giant right coronary artery aneurysm presenting as cardiac tamponade. Interact Cardiovasc Thorac Surg. 2018 11 01; 27(5):787-789.
    View on PubMed
  11. G. Woodard, S. Wang, J. Kratz, G. Haro, M. Gubens, C. Blakely, T. Jahan, K. Jones, M. Mann, D. Jablons. P2.16-12 Expanded Data Confirm Molecular Testing Identifies Lung Adenocarcinoma Patients, Including Stage IA, Who Benefit from Adjuvant Chemotherapy. Journal of Thoracic Oncology. 2018 Oct 1; 13(10):s835.
    View on PubMed
  12. G. Haro, J. Kratz, N. Cook, J. He, S. Van Den Eeden, G. Woodard, M. Gubens, T. Jahan, K. Jones, I. Kim, B. He, D. Jablons, M. Mann. P3.03-24 Incorporation of a Molecular Prognostic Classifier Improves Conventional Non-Small Cell Lung Cancer Staging. Journal of Thoracic Oncology. 2018 Oct 1; 13(10):s919.
    View on PubMed
  13. Greg J. Haro, Johannes R. Kratz, David M. Jablons, Michael J. Mann, Jasleen Kukreja. Propensity Matched Analysis of Perioperative Outcomes in Robotic-Assisted Thoracic Surgery, Video Assisted Thoracic Surgery, and Open Lung Resections. Journal of the American College of Surgeons. 2018 Oct 1; 227(4):s53.
    View on PubMed
  14. Ramirez J, Wieselthaler G, Kratz J. Intraoperative identification and treatment of a giant right coronary artery aneurysm. Multimed Man Cardiothorac Surg. 2018 Jul 24; 2018.
    View on PubMed
  15. Ramirez JL, Urisman A, Kukreja J, Kratz JR. Surgical Management of Pulmonary Mucormycosis in Third-Trimester Pregnancy. Thorac Cardiovasc Surg Rep. 2018 Jan; 7(1):e27-e29.
    View on PubMed
  16. Woodard GA, Wang SX, Kratz JR, Zoon-Besselink CT, Chiang CY, Gubens MA, Jahan TM, Blakely CM, Jones KD, Mann MJ, Jablons DM. Adjuvant Chemotherapy Guided by Molecular Profiling and Improved Outcomes in Early Stage, Non-Small-Cell Lung Cancer. Clin Lung Cancer. 2018 01; 19(1):58-64.
    View on PubMed
  17. Kratz JR, Woodard G, Jablons DM. Management of Lung Cancer Invading the Superior Sulcus. Thorac Surg Clin. 2017 May; 27(2):149-157.
    View on PubMed
  18. Gavitt Woodard, Jane Crockard, Clara Zoon-Besselink, Johannes Kratz, Matthew Gubens, Thierry Jahan, Collin Blakely, Kirk Jones, Michael Mann, David Jablons. OA19.06 Adjuvant Chemotherapy Decisions Based on Molecular Risk Status Improves Outcomes in Early Stage, Non-Small Cell Lung Cancer. Journal of Thoracic Oncology. 2017 Jan 1; 12(1):s320.
    View on PubMed
  19. Johannes Kratz, Nancy Cook, Gavitt Woodard, Kirk Jones, Matthew Gubens, Thierry Jahan, Il-Jin Kim, Biao He, David Jablons, Michael Mann. P1.03-066 Incorporation of a Molecular Prognostic Classifier Improves Conventional Non-Small Cell Lung Cancer TNM Staging Topic: Staging. Journal of Thoracic Oncology. 2017 Jan 1; 12(1):s584-s585.
    View on PubMed
  20. Shah JA, Patel MS, Kratz JR, Markmann JF, Vagefi PA. High risk, high reward: An analysis of outcomes for candidates awaiting hepatic re-transplantation. Ann Hepatol. 2016 Nov - Dec; 15(6):888-894.
    View on PubMed

Go to UCSF Profiles, powered by CTSI